Detalhe da pesquisa
2.
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests.
Circulation
; 149(3): 192-203, 2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37632469
3.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
N Engl J Med
; 387(20): 1855-1864, 2022 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36342163
4.
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.
Arterioscler Thromb Vasc Biol
; 44(5): 1156-1164, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38545781
5.
Bempedoic acid: new evidence and recommendations on use.
Curr Opin Lipidol
; 35(1): 41-50, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38085172
6.
Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?
Curr Opin Lipidol
; 35(1): 1-6, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37910156
7.
VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys.
J Lipid Res
; 65(2): 100497, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38216056
8.
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial.
Am Heart J
; 269: 179-190, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38160917
9.
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?
Curr Atheroscler Rep
; 26(3): 59-71, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38165521
10.
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy.
Curr Atheroscler Rep
; 26(4): 103-109, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38289577
11.
Identification of benzothiazoles as novel PCSK9 inhibitors.
Bioorg Med Chem Lett
; 97: 129542, 2024 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37939861
12.
Updates on Non-Statin LDL-Lowering Therapy.
Curr Cardiol Rep
; 26(4): 221-231, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38436784
13.
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Eur Heart J
; 44(25): 2277-2291, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37130090
14.
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Eur Heart J
; 44(2): 129-138, 2023 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36331326
15.
[First-line treatment of hypercholesterolemia : start with statin monotherapy or ezetimibe-statin combination ?] / Comment je traite...une hypercholestérolémie en première intention : statine seule ou combinaison ézétimibe-statine d'emblée ?
Rev Med Liege
; 79(4): 202-207, 2024 Apr.
Artigo
Francês
| MEDLINE | ID: mdl-38602206
16.
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review.
Curr Opin Lipidol
; 34(6): 243-251, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37606894
17.
Updates in the management of pediatric dyslipidemia.
Curr Opin Lipidol
; 34(4): 156-161, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36942877
18.
Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
Curr Opin Lipidol
; 34(6): 252-258, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37594008
19.
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans.
J Lipid Res
; 64(1): 100316, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36410424
20.
Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 Inhibition.
Annu Rev Med
; 72: 447-458, 2021 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33234004